Hope for renal denervation despite major trial failure

Renal denervation is not dead despite the failure of the first sham-controlled trial in the field, a major Australian cardiology conference has been told.

Associate professor Gerard Wilkins, an interventional cardiologist from the University of Otago and consultant at Dunedin and Mercy hospitals, says more trials are needed to tease out predictors of success for the procedure, used to treat resistant hypertension.